Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,820,859 papers from all fields of science
Search
Sign In
Create Free Account
EMD 273063 antibody, human
Known as:
Hu 14.18/IL - 2 Fusion Protein
, hu14.18-interleukin-2 fusion protein
, EMD 273063
Expand
A recombinant protein consisting of the hu14.18 monoclonal antibody fused to the cytokine interleukin-2 (IL2) with potential antineoplastic activity…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Cytotoxic T-Lymphocytes
NCIt Antineoplastic Agent Terminology
Receptor Activation Process
T-Cell Activation
Expand
Broader (2)
Interleukin-2
Monoclonal Antibodies
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Developing immunocombination therapy for Neuroblastoma using a Mycn tumor model
M. Kroesen
,
M. Kroesen
,
M. Kroesen
,
Krimpen aan den IJssel
,
M. Brok
2015
Corpus ID: 58815778
Neuroblastoma (NBL) is an aggressive malignancy of the sympathetic nervous system (NS). Advanced stage neuroblastomas prove fatal…
Expand
2014
2014
In vivo synergy of radiation and hu14.18-IL2 immunocytokine results in a memory T cell response in a syngeneic murine melanoma model
Zachary S Morris
,
Emily I. Guy
,
+7 authors
P. Sondel
Journal of Immunotherapy for Cancer
2014
Corpus ID: 264158321
Purpose Tumor-specific monoclonal antibodies (mAb) are a common type of immunotherapy capable of engaging innate immune cells to…
Expand
2012
2012
Abstract 1538: Enhanced antitumor effects of intratumoral (IT) hu14.18-IL2 immunocytokine (IC) compared to intravenous (IV) hu14.18-IL2 are distinguished by increased activated tumor infiltrating…
Richard K. Yang
,
Nicholas A. Kalogriopoulos
,
+9 authors
P. Sondel
2012
Corpus ID: 71693419
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Introduction: Hu14.18-IL2 (APN301, Apeiron…
Expand
2012
2012
Preclinical and clinical development of intratumorally administered hu14.18-IL2 as treatment for neuroblastoma and melanoma: the importance of tumor infiltrating leukocytes in tumors treated with…
Richard K. Yang
2012
Corpus ID: 79059364
2010
2010
Genotypes of NK cell KIR Receptors , Their Ligands , and Fc γ Receptors in the Response of Neuroblastoma Patients to Hu 14 . 18-IL 2 Immunotherapy : A Children ’ s Oncology Group Report #
D. Delgado
,
J. Hank
,
+14 authors
P. Sondel
2010
Corpus ID: 46735534
Response to immunocytokine (IC) therapy is dependent on natural killer (NK) cells in murine neuroblastoma (NBL) models…
Expand
2010
2010
Clinical Studies Genotypes of NK Cell KIR Receptors , Their Ligands , and Fc g Receptors in the Response of Neuroblastoma Patients to Hu 14 . 18-IL 2 Immunotherapy
David C. Delgado
,
J. Hank
,
+14 authors
P. Sondel
2010
Corpus ID: 37599892
Response to immunocytokine (IC) therapy is dependent on natural killer cells in murine neuroblastoma (NBL) models. Furthermore…
Expand
Review
2008
Review
2008
Anti-neuroblastoma activity of hu14.18-IL2 against minimal residual disease in a Children’s Oncology Group (COG) phase II study
S. Shusterman
,
W. London
,
+7 authors
P. Sondel
2008
Corpus ID: 74741270
3002 Background: The hu14.18-IL2 fusion protein consists of IL2 linked to a humanized mAb that recognizes the GD2…
Expand
2008
2008
Phase II trial of hu14.18-IL2 (EMD 273063) for patients with metastatic melanoma
M. Albertini
,
J. Hank
,
+7 authors
P. Sondel
2008
Corpus ID: 78712631
9039 Background: The hu14.18-IL2 immunocytokine consists of a humanized anti-GD2 monoclonal antibody linked to IL2. It has potent…
Expand
2001
2001
Immunozytokine
K. Sturmhoefel
,
A. Harstrick
Der Onkologe
2001
Corpus ID: 264020096
Immuntherapie von Krebs hat eine lange Geschichte. Die bisher erfolgreichsten Ansätze beruhen auf Antikörpern (AK) mit einer…
Expand